On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentrates. 1987

M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
Department of Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden.

A multicentre study was undertaken in order to determine the reliability of the methods of assay of F VIII:C and the position of the peak value obtained after infusion of F VIII:C concentrates. Blood samples were drawn before and 10, 30 and 60 min after injection of F VIII concentrates in six haemophiliacs in one of the centres. Coded, frozen plasma samples were dispatched to the laboratories of the other four centres. F VIII:C was determined by different one-stage methods using the same international standard but with different activators. The results of the different laboratories differed widely and no agreement was reached on the existence of a lag period. To reach a valid conclusion not only the same sample has to be analysed, as in this study, but also the same laboratory technique has to be used by all participating investigators. To reach agreement on in vivo recovery and on elimination curves for different F VIII concentrates multicentre studies must be based on reliable methods of assay.

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
December 1986, Thrombosis research,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
January 1984, Scandinavian journal of haematology. Supplementum,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
January 2017, Methods in molecular biology (Clifton, N.J.),
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
January 1984, Scandinavian journal of haematology. Supplementum,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
April 2004, Journal of thrombosis and haemostasis : JTH,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
November 2011, Thrombosis and haemostasis,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
January 1984, Scandinavian journal of haematology. Supplementum,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
January 1984, Scandinavian journal of haematology. Supplementum,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
August 1992, British journal of haematology,
M Blombäck, and H Kjellman, and J P Allain, and U Hedner, and K Schimpf, and B Wiechel
November 2007, Vox sanguinis,
Copied contents to your clipboard!